Table 3.
Factors Associated With Overall Survival.a
Univariate analysis | Multivariate analysis | |||
---|---|---|---|---|
HR (95% CI) | P value | HR (95% CI) | P value | |
Gender (male vs female) | 1.812 (1.115-2.947) | .017 | 1.521 (0.923-2.506) | .100 |
Age, years (>60 vs ≤60) | 1.120 (0.729-1.721) | .605 | ||
Rescue therapy (TACL-ECF vs Sorafenib) | 0.817 (0.532-1.255) | .357 | ||
Child-Pugh class (B/A) | 2.037 (1.302-3.187) | .002 | 1.976 (1.240-3.150) | .004 |
BCLC stage (C/B) | 3.023 (1.709-5.345) | <.0001 | 2.965 (1.638-5.364) | <.0001 |
Serum AFP, ng/mL (>200 vs ≤200) | 1.661 (1.076-2.563) | .022 | 1.157 (0.734-1.823) | .531 |
Abbreviations: AFP, α-fetoprotein; BCLC, Barcelona Clinic Liver Cancer; HR, hazard ratio.
a Cox proportional hazards model.